Skip to content

NOVELION THERAPEUTICS INC.

Delisted

CIK 827809fmd_04VG1JMFWFG3EPGQZK0GKWGJWYManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2009 to Mar 31, 2019, 38 periods

Latest annual · FY2018

Millions
Total revenues
130
Gross profit
71
Operating income
(50)
Net income
(108)
Free cash flow
(56)

Latest quarter · Q1 FY2019

Millions
Total revenues
32
Gross profit
17
Operating income
(16)
Net income
(32)
Free cash flow
8
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2015 to FY2018
n/m
Revenue, 5 yearsFY2013 to FY2018
n/m
Net income, 5 yearsFY2013 to FY2018
n/m

NOVELION THERAPEUTICS INC. financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2018FY2017ChangeSource
Revenue$130.4 million$138.4 million-5.8%10-K 2019-03-15 · proof
Gross profit$70.7 million$61.2 million+15.5%10-K 2019-03-15 · proof
Operating income-$50.1 million-$86.8 million10-K 2019-03-15 · proof
Net income-$108.3 million-$126.7 million10-K 2019-03-15 · proof
Cash from operating activities-$55.5 million-$54.9 million10-K 2019-03-15 · proof
Free cash flow-$55.9 million-$55.7 million10-K 2019-03-15 · proof
Total assets$341.7 million$369.3 million-7.5%10-K 2019-03-15 · proof
Total liabilities$430.6 million$354.4 million+21.5%10-K 2019-03-15 · proof
Cash and cash equivalents$45.2 million$55.4 million-18.5%10-K 2019-03-15 · proof
What was NOVELION THERAPEUTICS INC.'s revenue in fiscal 2018?
NOVELION THERAPEUTICS INC. reported revenue of $130.4 million for fiscal 2018 (the year ended Dec 31, 2018), against $138.4 million the year before (-5.8%). Source: the 10-K filed with the SEC on Mar 15, 2019. SEC
What was NOVELION THERAPEUTICS INC.'s gross profit in fiscal 2018?
NOVELION THERAPEUTICS INC. reported gross profit of $70.7 million for fiscal 2018 (the year ended Dec 31, 2018), against $61.2 million the year before (+15.5%). Source: the 10-K filed with the SEC on Mar 15, 2019. SEC
What was NOVELION THERAPEUTICS INC.'s operating income in fiscal 2018?
NOVELION THERAPEUTICS INC. reported operating income of -$50.1 million for fiscal 2018 (the year ended Dec 31, 2018), against -$86.8 million the year before. Source: the 10-K filed with the SEC on Mar 15, 2019. SEC
What was NOVELION THERAPEUTICS INC.'s net income in fiscal 2018?
NOVELION THERAPEUTICS INC. reported net income of -$108.3 million for fiscal 2018 (the year ended Dec 31, 2018), against -$126.7 million the year before. Source: the 10-K filed with the SEC on Mar 15, 2019. SEC
What was NOVELION THERAPEUTICS INC.'s cash from operating activities in fiscal 2018?
NOVELION THERAPEUTICS INC. reported cash from operating activities of -$55.5 million for fiscal 2018 (the year ended Dec 31, 2018), against -$54.9 million the year before. Source: the 10-K filed with the SEC on Mar 15, 2019. SEC
What was NOVELION THERAPEUTICS INC.'s free cash flow in fiscal 2018?
NOVELION THERAPEUTICS INC. reported free cash flow of -$55.9 million for fiscal 2018 (the year ended Dec 31, 2018), against -$55.7 million the year before. Source: the 10-K filed with the SEC on Mar 15, 2019. SEC
What are NOVELION THERAPEUTICS INC.'s total assets?
As of Dec 31, 2018, NOVELION THERAPEUTICS INC. reported total assets of $341.7 million, against $369.3 million a year earlier (-7.5%). Source: the 10-K filed with the SEC on Mar 15, 2019. SEC
What are NOVELION THERAPEUTICS INC.'s total liabilities?
As of Dec 31, 2018, NOVELION THERAPEUTICS INC. reported total liabilities of $430.6 million, against $354.4 million a year earlier (+21.5%). Source: the 10-K filed with the SEC on Mar 15, 2019. SEC
What are NOVELION THERAPEUTICS INC.'s cash and cash equivalents?
As of Dec 31, 2018, NOVELION THERAPEUTICS INC. reported cash and cash equivalents of $45.2 million, against $55.4 million a year earlier (-18.5%). Source: the 10-K filed with the SEC on Mar 15, 2019. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:827809&period_type=annual&limit=5"

Information only, not investment advice.